Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-207-4 | CAS number: 2386-87-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Carcinogenicity
Administrative data
Description of key information
A mouse skin-painting study is available.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Link to relevant study records
- Endpoint:
- carcinogenicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1964
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Remarks:
- Well conducted study consistent with best practice scientific methods available at the time of conduct
- Qualifier:
- according to guideline
- Guideline:
- other: The study was performed in accordance with contemporary published methods for the assessment of dermal carcinogenicity
- Version / remarks:
- Holt JP, Hendricks NV, Edkardt RE, Stanton CL & Page RC (1951). A cancer-control program for high-boiling catalytically cracked oils. AMA Arch Ind Hyg Occ Med 4: 325-334.
- Qualifier:
- according to guideline
- Guideline:
- other: The study was performed in accordance with contemporary published methods for the assessment of dermal carcinogenicity
- Version / remarks:
- Twort CC & Twort JM (1933). Suggested methods for the standardization of the carcinogenic activity of different agents for the skin of mice. Am J Cancer 17:293-320.
- Qualifier:
- according to guideline
- Guideline:
- other: The study was performed in accordance with contemporary published methods for the assessment of dermal carcinogenicity
- Version / remarks:
- Spicer CC (1947). The estimation of tumour susceptibility in pure lines. Brit J Cancer 1:298-310.
- Qualifier:
- according to guideline
- Guideline:
- other: The study was performed in accordance with contemporary published methods for the assessment of dermal carcinogenicity
- Version / remarks:
- Berenblum I (1945). A system of grading carcinogenic potency. Cancer Res 5:561-564.
- Qualifier:
- according to guideline
- Guideline:
- other: The study was performed in accordance with contemporary published methods for the assessment of dermal carcinogenicity
- Version / remarks:
- Blanding FH, King WH Jr., Priestly W Jr & Rehner J Jr. (1951). Properties of high-boiling petroleum products: quantitative analysis of tumor-response data obtained from the application of refinery products to the skin of mice. AMA Arch Ind Hyg Occ Med. 4:335-345.
- Principles of method if other than guideline:
- The study was performed in accordance with contemporary published methods for the assessment of dermal carcinogenicity, involving chronic dermal (skin painting) exposure in mice. Methods for this study were developed in the late 1940s-1950s by a group of scientists from Standard Oil Company, Esso Standard Oil Company, Lago Oil and Transport Company, Ltd, Humble Oil and Refining Company, Imperial Oil Company, Ltd., New York University-Bellevue Medical Center, and Memorial Hospital, New York, who investigated the effects of various petroleum distillates on skin tumour production. Methods were developed in an effort to define recommended industrial hygiene practices for petroleum workers who were assumed to cleanse skin less than once daily, and who could thus potentially be dermally exposed to petroleum products for extended periods during the workday and beyond (Holt et al., 1951). Methods were based on investigatory work conducted over the previous 20 years (Twort and Twort, 1933; Spicer, 1947; Berenblum, 1945). Choice of frequency of skin painting was based on anticipated potency of the material: 1x per week, high potency; 3x per week, lower potency; 3x to 6x/week, lowest potency (Dr. A. Wesley Horton, Kettering Laboratory, College of Medicine of University of Cinncinnati, personal communication in Union Carbide Corp. study 14-60).
Groups of 40 male mice were painted with a brushful (~ 0.-0.2 g; series 197 #1 Grumbacher brush) of the substance three times a week during their lifetimes; the substance was applied to the clipped intrascapular region of the backs. Backs were clipped once a week to ensure the application surface was clear of hair. The mice were usually painted on Mondays, Wednesdays, and Fridays, in an area ~1 cm in diameter above the shoulder blades. Each painting consisted of a single brush-stroke against the direction of the hair. Mice were examined on dosing days, and the number of surviving mice bearing papillomas or cancers recorded. Notes were kept on the position of tumours, course of progression of the tumours, and necropsy results. Tumours were examined microscopically. - GLP compliance:
- no
- Remarks:
- the study pre-dates the introduction of GLP
- Specific details on test material used for the study:
- The test material, as defined in this study, is named EP-221, and is composed of pure 7-OXABICYCLO(4.1.0)HEPTANE-3-CARBOXYLIC ACID, 7-OXABICYCLO(4.1.0)HEPT-3-YLMETHYL ESTER. The submission substance, ERL-4221, is composed of 82-89% 7-OXABICYCLO(4.1.0)HEPTANE-3-CARBOXYLIC ACID, 7-OXABICYCLO(4.1.0)HEPT-3-YLMETHYL ESTER.
- Species:
- mouse
- Strain:
- C3H
- Details on species / strain selection:
- This strain of mouse was commonly used in the skin painting studies.
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Male C3H/Anf mice were obtained from Cumberland Farms, TN, at approximately 4 weeks of age and were first dosed when approximately 3 months of age. Mice were group-housed 10/cage for the course of the study; partially depleted cages were never recombined. Mice received a standard rodent chow to eat and municipal tap water to drink.
- Route of administration:
- dermal
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- Groups of 40 male mice were painted with a brushful (~ 0.1-0.2 g; series 197 #1 Grumbacher brush) of the substance three times a week during their lifetimes; the substance was applied to the clipped intrascapular region of the backs. Backs were clipped once a week to ensure the application surface was clear of hair. The mice were usually painted on Mondays, Wednesdays, and Fridays, in an area ~1 cm in diameter above the shoulder blades. Each painting consisted of a single brush-stroke against the direction of the hair.
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- Undiluted test material was used for the study; therefore no dose solution checks were necessary.
- Duration of treatment / exposure:
- Lifetime (until moribund or dead) - up to 29 months
- Frequency of treatment:
- Three times per week, usually Monday, Wednesday, and Friday.
- Post exposure period:
- None
- Dose / conc.:
- 4 000 mg/kg bw/day (nominal)
- Remarks:
- The applied dose was estimated to be 4000-8000 mg/kg bw, based on 0.1-0.2 g applied to a mouse of 25 g bodyweight
- No. of animals per sex per dose:
- 40 males
- Control animals:
- yes
- other: A control group was treated with acetone, the vehicle used for the positive control group
- Details on study design:
- Methods for this study were developed in the late 1940s-1950s by a group of scientists from Standard Oil Company, Esso Standard Oil Company, Lago Oil and Transport Company, Ltd, Humble OIl and Refining Company, Imperial Oil Company, Ltd., New York University-Bellevue Medical Center, and Memorial Hospital, New York, who investigated the effects of various petroleum distillates on skin tumour production. Methods were developed in an effort to define recommended industrial hygiene practices for petroleum workers who were assumed to cleanse skin less than once daily, and who could thus potentially be dermally exposed to petroleum products for extended periods during the workday and beyond (Holt et al., 1951). Methods were based on investigatory work conducted over the previous 20 years (Twort and Twort, 1933; Spicer, 1947; Berenblum, 1945).
- Positive control:
- 3-methylcholanthrene (3-MC)
- Observations and examinations performed and frequency:
- The study focussed on the potential of the test material to cause skin tumours; other observations were limited.
Mice were examined on treatment days for general health and well-being, and observed monthly for tumour incidence. Whenever a growth was first noted by handlers, its nature was verified by the lead scientist and its position noted diagramatically. Progression or regression of the growth was documented similarly. The number of surviving mice in a given dose group was documented for each observation point. - Sacrifice and pathology:
- Moribund or dead mice were submitted for necropsy and the results recorded. Tumours were preserved and examined histologically for confirmation of tumour type.
- Other examinations:
- Data recorded in support of statistical analysis (Blanding et al., 1951):
Original number of mice per dose group
Time of observation (expressed in days) from the commencement of skin painting)
Number of deaths in each interval of observation
Number of tumour-free animals that died in each interval
Number of tumour (papilloma)-bearing animals that died in each interval
Number of cancer (carcinoma)-bearing animals that died in each interval
Total number of survivors at each time of observation
Number of tumour-free survivors at each time of observation
Number of tumour (papilloma)-bearing survivors at each time of observation
Number of cancer (carcinoma)-bearing survivors at each time of observation - Statistics:
- For each time of observation, the percent tumor response was computed according to the following equation:
Percent tumour response was defined as the total number of mice with tumours/effective number of mice
The total number of mice with tumours was defined as the cumulative number of mice that died with papillomas and/or carcinomas up to the time of observation plus the current number of survivors having papillomas and/or carcinomas. That is, the numerator measures the total response for both living and dead mice, the word tumour was used without differentiation between benign and malignant forms. The denominator is computed as the original number of mice less the number that have died without any tumours up to the time of observation.
Similarly, a percent cancer response was calculated for each time of observation.
Percent tumour or percent cancer response was plotted against time logarithmically to obtain a dose-response line (probit plot). Tumour potency was then calculated as the tumour-response rate as follows:
Tumour potency = 10,000 / days to 50% tumour response (Finney, 1947). The denominator was derived from the logarithmic plot described above. An analogous calculation was done for cancer potency. Average latency period was calculated by plotting the percent response indices against time and determining the time to achieve a 50% response via a least-squares method. This was compared for the test substance vs. negative and positive controls using standard categorical analysis for the time period. - Clinical signs:
- not examined
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- mortality observed, non-treatment-related
- Body weight and weight changes:
- not examined
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Only one skin tumour was seen (this after 23 months of painting) and this was less than the 2 tumours seen on mice that received acetone paintings
- Other effects:
- not specified
- Details on results:
- Only one tumour was seen in the treated group (after 23 months of painting) and this was less than the 2 tumours seen on the control mice that received acetone paintings. Therefore, undiluted EP-221 was not, by this test, tumorigenic to the skin of mice.
EP-221: Number of mice alive at one year, 39; 18 months, 31; 24 months, 12
Appearance of tumour: Month 23 of painting, 15 mice still alive
Tumour index: 6.7
Cancer index: 0.0
Average latency period for tumours: >29 months
Average latency period for cancer: n/a
Acetone control:
Number of mice alive at one year, 32; 18 months, 26; 24 months, 4.
Appearance of tumours: month 23 of painting, 5 mice still alive.
Tumour index: 40.0
Cancer index: 0.0
Average latency period for tumoursl >26 months
Average latency period for cancer; n/a
Positive control methyl cholanthrene (0.2% in acetone):
Number of mice alive at one year, 2; 18 months: 0 ; 24 months, 0
Appearance of tumours: Month 3 of painting, 40 mice still alive
Tumour index: 100.0
Cancer index: 94.9
Average latency period for tumours; 5.5 months
Average latency period for cancer; 7.2 months - Relevance of carcinogenic effects / potential:
- Only one tumour was seen in the treated group (after 23 months of painting) and this was less than the 2 tumours seen on control mice that received acetone paintings. Therefore, undiluted EP-221 was not, by this test, tumorigenic to the skin of mice.
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 4 000 - <= 8 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- histopathology: neoplastic
- Key result
- Critical effects observed:
- no
- Conclusions:
- Only one skin tumor developed in mice exposed to ~4000-8000 mg/kg/application of EP-221 for a lifetime. The tumor index was 6.7, and the average latent period was greater than 29 months. This compares to two tumors seen with application of the negative control, acetone, and 39 seen with the positive control, methyl cholanthrene.
- Executive summary:
In this study, the substance EP-221 (a purified form of the submission substance) was applied undiluted three times a week to the same position on the shorn dorsal skin of a group of 40 male C3H/Anf mice, aged 3 months. The substance was applied at a rate of 100-200 mg/mouse, calculated to be equivalent to 4000-8000 mg/kg bw. Application continued until death (or moribundity), which was up to 29 months (i.e. mice were treated for up to 26 months). A positive control group was similarly treated with 3‑methylcholanthrene (0.2% in acetone) and a negative (vehicle) control group was treated with acetone. Mice were observed daily and were assessed monthly for the development of skin tumours. Tumours were monitored for progression or regression and were assessed histopathologically as papillomas or carcinomas following the death of the animal. One mouse in the substance treatment group developed a skin tumour; the tumour was first observed from 26 months (i.e. after 23 months of treatment). Two control mice developed skin tumours; the latency period for these tumours was the same as for the treated group. All of the tumours in the treated and control groups were characterised histopathologically as papillomas. A total of 39 mice in the positive control group were observed to develop skin tumours. Tumours were observed from as early as 3 months and the vast majority (37 of 39 tumours) were characterised histopathologically as carcinomas. The results of this study therefore demonstrate an absence of skin carcinogenicity for the test material. The incidence, type and latency of skin tumours seen in this study were comparable to the control group. In contrast, administration of the known carcinogen 3-methylcholanthrene resulted in a very large proportion of treated mice with skin tumours. The study is relatively old and was not performed to current guidelines for the assessment of carcinogenicity. The study is, however, considered to be scientifically robust and was performed to a method suitable for the assessment of local (site of contact) carcinogenicity which was in widespread use at the time. The study is considered to be adequate in demonstrating a lack of carcinogenicity following repeated dermal application of the substance to mouse skin.
Reference
One mouse in the substance treatment group developed a skin tumour; the tumour was first observed from 26 months (i.e. after 23 months of treatment). Two control mice developed skin tumours; the latency period for these tumours was the same as for the treated group. All of the tumours in the treated and control groups were characterised histopathologically as papillomas. A total of 39 mice in the positive control group were observed to develop skin tumours. Tumours were observed from as early as 3 months and the vast majority (37 of 39 tumours) were characterised histopathologically as carcinomas.
Mouse skin-painting carcinogenicity study: summary of findings
Material |
Concentration |
Number* alive at |
Appearance of First Tumour |
Total no of mice with |
Max No of Months Painted |
Tumour Index |
Cancer Index |
Average Latency (mo) |
|||||
12 mo |
18 mo |
24 mo |
Month |
No alive |
Tumours |
Cancer |
Tumour |
Cancer |
|||||
EP-221 |
Undiluted |
36 |
35 |
17 |
23 |
15 |
1 |
0 |
29 |
6.7 |
0.0 |
-- |
-- |
Acetone |
Undiluted |
32 |
26 |
4 |
23 |
5 |
2 |
0 |
26 |
40.0 |
0.0 |
>26 |
-- |
3MC |
0.2% in acetone |
2 |
0 |
0 |
3 |
40 |
39 |
37 |
13 |
100.0 |
94.9 |
5.5 |
7.2 |
*40 mice started in each group |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 4 000 mg/kg bw/day
- Study duration:
- chronic
- Species:
- mouse
- Quality of whole database:
- The study is relatively old and was not performed to current guidelines for the assessment of carcinogenicity. The study is, however, considered to be scientifically robust and was performed to a method suitable for the assessment of local (site of contact) carcinogenicity which was in widespread use at the time. The study is considered to be adequate in demonstrating a lack of carcinogenicity following repeated dermal application of the substance to mouse skin.
- System:
- integumentary
- Organ:
- skin
Justification for classification or non-classification
No evidence of carcinogenicity was seen in the single available study. No classification is therefore proposed for cacrcinogenicity according to the CLP Regulation
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.